All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The SARS-CoV coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS-CoV). On April 16, 2003, following the outbreak of SARS-CoV in Asia and secondary cases elsewhere in the world, the World Health Organization (WHO) issued a press release stating that the coronavirus identified by a number of laboratories was the official cause of SARS-CoV.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-L104 | Human anti-SARS-CoV (GETALALLLL) T Cell Receptor, pMP71 | SARS-CoV | Human | GETALALLLL | HLA-B4001 | retroviral vector | ||
TCR-L103Z | Human anti-SARS-CoV (aa118-127) T cell receptor (Cysteine-modified), pCDTCR1 | SARS-CoV | Human | GETALALLLL | HLA-B4001 | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION